She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
She speaks about her recent systematic review and meta-analysis that aimed to determine the risk of adverse maternal, placental, and obstetric outcomes in women with inflammatory bowel disease.
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
In this podcast, William R. Hiatt, MD, provides insight into a new subgroup analysis of the VOYAGER-PAD trial, which revealed whether adding clopidogrel to the rivaroxaban and aspirin regime of a patient...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
Jim Oates, MD, and Joy Buie, PhD, MSCR, from The Medical University of South Carolina, discuss their research on nitric oxide synthase as a potential target for vascular disease among individuals with...
Neurology Consultant Advisory Board Member Rachel Salas, MD, discusses her experiences in caring for her patients with sleep disorders via telemedicine, how medical education is changing for her neurology...
